Monitoring, Detoxifying, and Rebalancing Metals During Acute Myeloid Leukemia (AML) Therapy, a Phase 2 Randomized Study

NCT06811233 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

140

Enrollment

OTHER

Sponsor class

Conditions

Acute Myeloid Leukemia (AML)

Interventions

DRUG: DMSA
DRUG: Ca-EDTA
DRUG: Magnesium Sulfate
DRUG: Multivitamin

Sponsor

M.D. Anderson Cancer Center

Collaborators

[object Object]